Skip to main content
German
Nevro Corp Logo Nevro Corp Logo Nevro Corp Logo
  • US
    • Home
    • Providers
      • Overview
      • Product: HFX iQ
      • Product: Trial Stimulator
      • Product: Omnia
      • HFX for Non-Surgical Back Pain
      • HFX for PDN
      • HFX Services and Support
      • HFX Advanced Therapies
      • HFX Meaningful Evidence
      • Product manuals
      • Reimbursement
      • Grants
    • Patients
      • Overview
      • Patient manuals
    • Publications
    • About
      • Overview
      • Leadership team
      • Newsroom
      • Contact Us
      • Email alerts
    • Safety
    • Careers
      • Overview
      • Culture
      • Benefits
      • Opportunities
      • Fraud Alert
    • Investors
      • Overview
      • Investor news
      • Stock information
      • Financial information
      • Events & presentations
      • ESG
      • Corporate governance
      • Investors FAQ
  • EN
    • Home
    • Providers
      • Overview
      • Product: Omnia
      • HFX for PDN
      • HFX Services and Support
      • HFX Advanced Therapies
      • HFX Meaningful Evidence
      • Product Manuals
      • Grants
    • Patients
      • Patient Manuals
    • Outcomes
    • About
      • Overview
      • Leadership Team
      • Newsroom
      • Contact Us
    • Safety
    • Careers
      • Overview
      • Culture
      • Opportunities
    • Investors
  • AU
    • Home
    • Providers
      • Overview
      • Product: Omnia
      • HFX for PDN
      • HFX Services and Support
      • HFX Advanced Therapies
      • HFX Meaningful Evidence
      • Product manuals
      • Grants
    • Patients
      • Patient manuals
    • Publications
    • About
      • Overview
      • Leadership team
      • Newsroom
      • Contact Us
      • Email alerts
    • Safety
    • Careers
      • Overview
      • Culture
      • Benefits
      • Opportunities
      • Fraud Alert
    • Investors

Reimbursement

Nevro’s patient access program, HFX Access™, is available to assist patients in navigating the prior authorization process for HFX SCS Therapy. Access can support your patients' pathway to approval including:

  • Benefit Verification
  • Prior Authorization
  • Pre-Determination
  • Denial Support through the internal and external appeal process
  • Billing/Coding/Coverage questions
Patient Forms
Download File

Coverage

HFX SCS Therapy is covered by nearly all major insurance plans, including Medicare, as a late or last resort therapy for chronic intractable back and leg pain. Payers continue to add painful diabetic neuropathy (PDN) as a covered indication for HFX SCS therapy based upon Nevro’s published level one Randomized Controlled Trial (RCT) evidence for PDN.

Most payers require prior authorization for SCS to show that the patient is refractory to conventional medical management (CMM). Nevro’s Market Access team can provide up-to-date spinal cord stimulation coverage policies for any insurance plan. These policies highlight the covered indications and specific documentation requirements. Please reach out to Market.Access@nevro.com for details.

Reimbursement Guide

This Reimbursement Guide is an interactive PDF covering the common questions and barriers of reimbursement including the following sections:

  • Coverage – Includes a Medicare Coverage Map and details on requirements of psychological evaluations and surgical consultations
  • Coding – Organized lists of CPT, ICD-10-CM, and relevant HCPCS codes
  • Payment – Medicare National average reimbursement amounts
  • Patient Access – Overview of HFX Access including how to utilize this service and background on important documents

Contact Us

Email: Market.Access@nevro.com

Nevro Corp Logo
Nevro Corp Logo
Nevro Corp Logo
  • PROVIDERS
  • PATIENTS
  • OUTCOMES
  • ABOUT
  • CAREERS
  • SAFETY
  • PROVIDERS
  • PATIENTS
  • OUTCOMES
  • INVESTORS
  • ABOUT
  • CAREERS
  • SAFETY
  • PROVIDERS
  • PATIENTS
  • OUTCOMES
  • INVESTORS
  • ABOUT
  • CAREERS
  • SAFETY
  • Terms of Use
  • Patents
  • Terms & Conditions
  • Cookie Notice
  • Privacy
  • Corporate Governance
  • Terms of Use
  • Patents
  • Privacy
  • Cookie Notice
  • Terms & Conditions
  • Terms of Use
  • Patents
  • Privacy
  • Cookie Notice
  • Terms & Conditions
© Nevro Corp. All rights reserved.
Powered By Q4 Inc. 5.91.0.8 (opens in new window)

YOU ARE ABOUT TO ACCESS A WEBSITE INTENDED FOR THE RESIDENTS OF A PARTICULAR COUNTRY OR REGION.

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result the site may contain information on medical devices and other products or uses of those products that are not approved in your country or region.

Please select from the below based on your location:
Australia USA Germany International - English Australia USA Germany International - English Australia USA Germany International - English

YOU ARE ABOUT TO EXIT FOR A WEBSITE INTENDED FOR THE RESIDENTS OF ANOTHER COUNTRY OR REGION.

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue?

THE WEBSITE YOU HAVE REQUESTED IS INTENDED FOR HEALTH CARE PROFESSIONALS ONLY.

If you are not a health care professional, you should not enter this website. By clicking "YES" you confirm your understanding of this disclaimer and attest that you are a health care professional.

Do you wish to continue?